Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05866081

Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative

Led by University of Michigan · Updated on 2025-12-15

792

Participants Needed

16

Research Sites

152 weeks

Total Duration

On this page

Sponsors

U

University of Michigan

Lead Sponsor

P

Patient-Centered Outcomes Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a multicenter prospective trial with randomized and observational cohorts assessing patient-reported outcomes and unplanned healthcare utilization following ureteroscopic treatment of renal and ureteral stones, with placement versus omission of a ureteral stent. Eligible participants in the randomization trial will be randomized to ureteroscopy with stent placement or stent omission. Eligible participants that consent to the observational only cohort will complete surveys and the treating physicians will decide the treatment options for the participants. The study team hypothesizes that: * Pain interference change from pre-surgery to Day 7-10 will differ between the two treatment arms. This hypothesis will be evaluated separately in the randomized and observational cohorts. * Unplanned healthcare utilization in the treatment arms will have different unplanned healthcare utilization ranks leading to a win proportion significantly higher or lower than 0.5 in the stent omission arm compared to the stent placement arm. This hypothesis will be evaluated separately in the randomized and observational cohorts.

CONDITIONS

Official Title

Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Undergoing unilateral ureteroscopy and lithotripsy for stone disease (contralateral stones must be asymptomatic and untreated)
  • Largest stone is 10 millimeters or smaller as measured by abdominal x-ray, ultrasound, or CT scan
  • Access to communication methods such as email, text messaging, or telephone
  • Adequate cognitive function and English proficiency to complete surveys
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • Planned bilateral ureteroscopy
  • Existing ureteral stent or nephrostomy tube in either kidney before surgery
  • Anatomic abnormalities of the ipsilateral upper urinary tract (e.g., horseshoe kidney, crossed fused ectopia, pelvic kidney, urinary diversion)
  • Solitary kidney due to anatomy or function
  • Planned secondary or staged ureteroscopy
  • Planned use of ureteral access sheath
  • Pregnancy
  • Daily opioid medication use for over 3 months to manage pain
  • Ureteral perforation during surgery
  • Unexpected anatomic abnormalities found during surgery
  • Excessive bleeding during surgery
  • Ureteral dilation greater than 12 French
  • Use of ureteral access sheath during surgery
  • Failed ureteroscopy
  • No or incomplete lithotripsy performed
  • Surgery incomplete due to medical or anesthetic issues

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 16 locations

1

University of Arizona

Tucson, Arizona, United States, 85724

Actively Recruiting

2

UF Health Shands Hospital

Gainesville, Florida, United States, 32608

Actively Recruiting

3

Indiana University Department of Urology

Indianapolis, Indiana, United States, 46202

Actively Recruiting

4

University of Michigan Health System

Ann Arbor, Michigan, United States, 48111

Actively Recruiting

5

University of Michigan Health System

Brighton, Michigan, United States, 48116

Actively Recruiting

6

Cadillac Munson Hospital

Cadillac, Michigan, United States, 49601

Actively Recruiting

7

St. Joseph Health System Chelsea Hospital

Chelsea, Michigan, United States, 48118

Actively Recruiting

8

St. Joseph Mercy Health (Trinity)

Chelsea, Michigan, United States, 48118

Actively Recruiting

9

Henry Ford Health System

Detroit, Michigan, United States, 48202

Actively Recruiting

10

Corewell Health Buttersworth Hospital

Grand Rapids, Michigan, United States, 49503

Actively Recruiting

11

E.W Sparrow Hospital

Lansing, Michigan, United States, 48912

Actively Recruiting

12

MyMichigan Medical Center Midland

Midland, Michigan, United States, 48670

Actively Recruiting

13

Michigan Institute of Urology Town Center Ambulatory Surgery Center

Troy, Michigan, United States, 48084

Actively Recruiting

14

Monte Fiore

Brooklyn, New York, United States, 10467

Actively Recruiting

15

Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

16

UNC Hospital

Chapel Hill, North Carolina, United States, 27514

Actively Recruiting

Loading map...

Research Team

E

Elaina Shoemaker

CONTACT

S

Sabrina Clark

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative | DecenTrialz